Piramal Pharma Limited Capital Reinvestment Ratio
Piramal Pharma Limited capital reinvestment ratio. Piramal Pharma Limited (PPLPHARMA) has a Capital Reinvestment Ratio of 0.49x as of September 2025, meaning it reinvests 0% of its operating cash flow (Rs8.90 Billion) in capital expenditures (Rs4.33 Billion). See free cash flow generation of Piramal Pharma Limited to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Piramal Pharma Limited (2021–2026)
Capital reinvestment ratio of Piramal Pharma Limited from 2021 to 2026. This chart tracks Piramal Pharma Limited's Capital Reinvestment Ratio across 6 annual periods. See financial agility of Piramal Pharma Limited to measure the company's free cash flow as a share of total liabilities.
Piramal Pharma Limited Capital Reinvestment Ratio by Year (2021–2026)
Piramal Pharma Limited capital reinvestment ratio by year from 2021 to 2026. For the full cash flow conversion analysis, see how efficiently does Piramal Pharma Limited generate cash.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2026 | 0.64x | Rs14.00 Billion | Rs8.90 Billion | ▼ -14.6% |
| 2025 | 0.74x | Rs8.92 Billion | Rs6.64 Billion | ▲ +5.0% |
| 2024 | 0.71x | Rs10.05 Billion | Rs7.12 Billion | ▼ -64.4% |
| 2023 | 1.99x | Rs4.84 Billion | Rs9.65 Billion | ▲ +153.8% |
| 2022 | 0.79x | Rs2.55 Billion | Rs2.01 Billion | ▼ -53.1% |
| 2021 | 1.67x | Rs347.20 Million | Rs581.10 Million | — |